Abstract
The treatment of malignant gliomas with cisplatin has been shown to be of benefit. In order to reduce the side effects of the drug, we employed the use of sodium thiosulfate in ten patients one hour after cisplatin infusion and continued for 6 h. Side effects from this population of patients were compared with those side effects experienced with 13 patients not receiving thiosulfate. No real difference in number or severity of side effects from cisplatin was observed between the two groups although nephrotoxicity appeared to be reduced in the patients who received thiosulfate.
Similar content being viewed by others
References
Pfeifle CE, Howell SB, Felthouse RD, Woliver TBS, Andrews PA, Markman M, Murphy MP: High-dose cisplatin with sodium thiosulfate procection. J Clin Oncol 3:237–244, 1985.
Howell SB, Pfeifle CE, Wung WE, Olshen RA, Lucas WE, Yon JL, Green M: Intraperitoneal cisplatin with systemic thiosulfte protection. Ann Int Med 97:845–851, 1982.
DeConti RC, Toftness BR, Lange RC, Creasey WA: Clinical and pharmacological studies with cis-diamminedichloroplatinum (II). Cancer Res 33:1310–1315, 1973.
Himmelstein KJ, Patton TF, Belt RJ, Taylor S, Repta AJ, Sternson LA: Clinical kinetics of intact cisplatin and some related species. Clin Pharmacol Ther 29:658–664, 1981.
Gormley PE, Bull JM, LeRoy AF, Cysyk R: Kinetics of cis-dichlorodiammineplatinum. Clin Pharmacol Ther 25 (3):351–357, March, 1979.
Walker EM Jr, Gale GR: Methods of reduction of cisplatin nephrotoxicity. Ann Clin Lab Sci 11:397–410, 1981.
Kapp J, Vance R: Supraophthalmic carotid infusion for recurrent gliomass: rationale, technique, and preliminary results for cisplatin and BCNU. J Neuro-Oncol 3:5–11, 1985.
Howell SB, Pfeifle CE, Wung WE, Olshen: Intraperitoneal cis-diamminedichloroplatinum with systemic thiosulfate protection. Cancer Res 43:1426–1431, 1983.
Howell SB, Taetle: Effect of sodium thiosulfate of cis-dichlorodiammineplatinum (II) toxicity and antitumor activity in L1210 leukemia. Cancer Treat Rep 64:611–616, 1980.
Ishizawa M, Taniguchi S, Baba T: Protection by sodium thiosulfate and thiourea against lethal toxicity of cis-diamminedichloroplatinum (II) in bacteria and mice. Jap J Pharmacol 31:883–889, 1981.
Sagiyama K, Uozumi J, Aoki K, Baba T: Efficacy of ‘two-route chemotherapy’ using intra-arterial cisplatin and IV sodium thiosulfate, its antidote, in rate bladder tumor. Cancer Treat Rep 67:567–572, 1983.
Shea M, Koziol JA, Howell SB: Kinetics of sodium thiosulfate, a cisplatin neutralizer. Clin Pharmacol Ther 35 (3):419–425, March, 1984.
Sunderman FW: The treatment of acute nickel carbonyl poisoning with sodium diethyldithiocarbamate. Ann Clin Res 3:182–185, 1971.
Newman EV, Gilman A, Philips FS: The renal clearance of thiosulfate in man. Bull Johns Hopkins Hosp 79:229–242, 1946.
Uozumi J, Ishizawa M, Iwamoto Y, Baba T: Sodium thiosulfate inhibits cis-diamminedichloroplatinum (II) activity. Cancer Chemother Pharmacol 13:82–85, 1984.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Vance, R.B., Pittisapu, J. & Kappa, J.P. Experiences with sodium thiosulfate after intracarotid infusion of cisplatin and BCNU for malignant gliomas. J Neuro-Oncol 4, 151–154 (1986). https://doi.org/10.1007/BF00165375
Issue Date:
DOI: https://doi.org/10.1007/BF00165375